Thank you to our elected leaders and all of the AZBio Members  who joined us to honor them at Trailblazers 2017!

During our Trailblazers panel discussion, Dr. Andy Theodorou shared with us the important opportunity for each of us to become part of the All of Us research program.  You can help shape the future of medicine.  To learn how, click here 

AZBio Member News

Beacon Biomedical Inc. Announces the Launch of Its BeScreened™-CRC Test for Colorectal Cancer Screening

Phoenix, AZ.—Beacon Biomedical Inc., a medical diagnostic development company and CLIA laboratory based in Phoenix Arizona, today announced the launch of BeScreened™-CRC, a blood-based laboratory developed test (LDT) for colorectal cancer (CRC) screening that is 95% accurate at detecting CRC in adults ages 50-75 years of age with an overall 91% sensitivity and 86% specificity for CRC stages I-IV. Preliminary study findings also indicate a greater than 60% sensitivity for detecting precancerous polyps (advanced adenomas).

C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)

Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium announces its first clinical outcome assessment (COA) qualification from the US Food and Drug Administration (FDA) for the Symptoms of Major Depressive Disorder Scale (SMDDS). This qualification of the SMDDSfor exploratory use represents a major milestone for the PRO Consortium and specifically for the Depression Working Group, and is the culmination of a multi-year collaboration between FDA’s Center for Drug Evaluation and Research (CDER) and the PRO Consortium.

Baylor Scott & White Research Institute and TGen Poised to Create Early Detection Test for Pancreatic Cancer

$5.13 million National Cancer Institute grant funds research to help identify patients before the disease causes symptoms or spreads

UA Project Tackles Challenge of Making Safer Melons

With funding from the U.S. Department of Agriculture, researchers will develop new disinfectants, grow new breeds of melons, and educate farmers, retailers and consumers on safe melon production practices.

New imaging technology peers deep into the unfathomed 3D world of living single cells to advance disease diagnostics

Medical imaging technology like MRIs and CT scans have revolutionized the way patients are diagnosed with injuries and disease by enabling doctors to non-invasively look beneath the patient’s skin.

Opportunity Alerts

Post your open career opportunities today at  Jobs.AZBio.org

Do YOU have news to share with our community?  

Send your news and events to JKW@AZBio.org. 

Get Connected – Sign up today!